ABOUT THE PRODUCT
A bispecific antibody targeting BAFF-R and CD3, designed to induce B-cell depletion for the treatment of B-cell malignancies and autoimmune disorders.
Information is owner-confirmed
Last updated 5 months ago
Price range
Other products/services from Pepromene Bio
PMB-CT01 (BAFFR-CAR T cell therapy)
Biotechnology
N/A
Pepromene Bio
United States (US)